Evidence map›Paper›PMID 26310106›Full record

ArticleBiomaterials2015

Topographical effects on fiber-mediated microRNA delivery to control oligodendroglial precursor cells development.

Hua Jia Diao, Wei Ching Low, Q Richard Lu, Sing Yian Chew

Abstract read
In one paragraph

Article in Biomaterials, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Scaffold-Based Delivery of CRISPR/Cas9 Ribonucleoproteins for Genome Editing.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  8. Review
  9. Review
  10. Maneuvering the Migration and Differentiation of Stem Cells with Electrospun Nanofibers.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Review
  11. Review
  12. Article
  13. Review
  14. Mechanosensitivity of Human Oligodendrocytes.Frontiers in cellular neuroscience · 2020
    Article
  15. Article
  16. Scaffold-Mediated Sustained, Non-viral Delivery of miR-219/miR-338 Promotes CNS Remyelination.Molecular therapy : the journal of the American Society of Gene Therapy · 2019
    Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Hua Jia DiaoSchool of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore 637459, Singapore.
Wei Ching LowSchool of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore 637459, Singapore.
Q Richard LuDepartment of Pediatrics, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Sing Yian ChewSchool of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore 637459, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore. Electronic address: sychew@ntu.edu.sg.
Nanyang Technological University · SGCincinnati Children's Hospital Medical Center · US

Funding

Molecular Mechanisms of Oligodendrocyte Differentiation and MyelinationR01NS072427 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI LU, QING R · 2010 to 2018
$3.6M
Chromatin remodeling control of myelination and remyelinationR01NS075243 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI LU, QING R · 2012 to 2018
$2.6M
A Novel Model of Medulloblastoma to Define Cancer Pathways and Molecular TargetsR01NS078092 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI LU, QING R · 2012 to 2016
$1.7M
NINDS NIH HHS R01 NS072427NINDS NIH HHS R01 NS075243NINDS NIH HHS R01 NS078092
6 · The paper itself

Abstract

Effective remyelination in the central nervous system (CNS) facilitates the reversal of disability in patients with demyelinating diseases such as multiple sclerosis. Unfortunately until now, effective strategies of controlling oligodendrocyte (OL) differentiation and maturation remain limited. It is well known that topographical and biochemical signals play crucial roles in modulating cell fate commitment. Therefore, in this study, we explored the combined effects of scaffold topography and sustained gene silencing on oligodendroglial precursor cell (OPC) development. Specifically, microRNAs (miRs) were incorporated onto electrospun polycaprolactone (PCL) fiber scaffolds with different fiber diameters and orientations. Regardless of fiber diameter and orientation, efficient knockdown of differentiation inhibitory factors were achieved by either topography alone (up to 70%) or fibers integrated with miR-219 and miR-338 (up to 80%, p < 0.05). Small fiber promoted OPC differentiation by inducing more RIP(+) cells (p < 0.05) while large fiber promoted OL maturation by inducing more MBP(+) cells (p < 0.05). Random fiber enhanced more RIP(+) cells than aligned fibers (p < 0.05), regardless of fiber diameter. Upon miR-219/miR-338 incorporation, 2 μm aligned fibers supported the most MBP(+) cells (∼17%). These findings indicated that the coupling of substrate topographic cues with efficient gene silencing by sustained microRNA delivery is a promising way for directing OPC maturation in neural tissue engineering and controlling remyelination in the CNS.

Indexed as

Gene Transfer TechniquesAnimalsBiomarkersCell SurvivalFluorescent Antibody TechniqueGene Knockdown TechniquesMicroRNAsMicroscopy, Electron, ScanningNeural Stem CellsOligodendrogliaPolyestersRatsReal-Time Polymerase Chain ReactionTissue ScaffoldsBiomarkersMicroRNAspolycaprolactonePolyestersElectrospinningGene silencingMyelinationNanofibersOligodendrocytesSustained release

Identifiers

PMID26310106
PMCPMC4769075
OpenAlexW1475021316

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.